ACLY and type 2 diabetes mellitus: In the context of data from our current study that supported favourable effects of ACLY inhibition on the waist-to-hip ratio, we hypothesize that by beneficially impacting body fat distribution, ACLY inhibition may contribute to reduced T2DM risk in clinical practice.